Novartis To Pick Up French Cancer Drug Co. In $3.9B Deal
Novartis said Monday it will launch a $3.9 billion tender offer for France-based radiopharmaceutical company Advanced Accelerator Applications, as the Swiss pharmaceuticals company looks to strengthen its oncology offerings....To view the full article, register now.
Already a subscriber? Click here to view full article